Study International Multicentric Pancreatic Left Resections (SIMPLR): Does Surgical Approach Matter?

被引:1
|
作者
Acciuffi, Sara [1 ]
Hilal, Mohammed Abu [2 ]
Ferrari, Clarissa [3 ]
Al-Madhi, Sara [1 ]
Chouillard, Marc-Anthony [4 ]
Messaoudi, Nouredin [5 ]
Croner, Roland S. [1 ]
Gumbs, Andrew A. [1 ,6 ]
机构
[1] Univ Magdeburg, Dept Gen Visceral Vasc and Transplantat Surg, Leipziger Str 44, D-39120 Magdeburg, Germany
[2] Fdn Poliambulanza Ist Ospedaliero, Hepatobiliopancreat Robot & Minimally Invas Surg U, Via Bissolati 57, I-25124 Brescia, Italy
[3] Fdn Poliambulanza Ist Ospedaliero, Res & Clin Trials Off, Via Bissolati 57, I-25124 Brescia, Italy
[4] Univ Paris Cite, Hepatobiliopancreat Surg, 85 Blvd St Germain, F-75006 Paris, France
[5] Vrije Univ Brussel, Univ Ziekenhuis Brussel, Europe Hosp, Dept Hepatopancreatobiliary Surg, Laarbeeklaan 101, B-1090 Brussels, Belgium
[6] Amer Hosp Tbilisi, Dept Adv & Minimally Invas Surg, 17 Ushangi Chkheidze St, Tbilisi 0102, Georgia
关键词
left pancreatic resection; laparoscopy; robotic surgery; minimally invasive; multicentric; international; LAPAROSCOPIC DISTAL PANCREATECTOMY; ARTIFICIAL-INTELLIGENCE; OUTCOMES; SURGERY; FISTULA;
D O I
10.3390/cancers16051051
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary: Nowadays: minimal invasive distal pancreatectomy is becoming the standard approach for this procedure. Nevertheless, empirical evidence is still needed to validate the advantages associated with the various surgical approaches. This international retrospective multicenter cohort study conducted at three high-volume centers for HPB surgery attempted to compare the perioperative and oncological outcomes of the three primary surgical techniques-open, laparoscopic, and robotic-using propensity score matching analysis. The laparoscopic approach demonstrated notable benefits, including shorter operative times, lower blood loss, and reduced duration of both ICU and hospital stays. Furthermore, the robotic approach exhibited a significantly lower incidence of POPF. Notably, all three techniques demonstrated comparable levels of oncological safety, morbidity, and mortality. Background: Minimally invasive surgery is increasingly preferred for left-sided pancreatic resections. The SIMPLR study aims to compare open, laparoscopic, and robotic approaches using propensity score matching analysis. Methods: This study included 258 patients with tumors of the left side of the pancreas who underwent surgery between 2016 and 2020 at three high-volume centers. The patients were divided into three groups based on their surgical approach and matched in a 1:1 ratio. Results: The open group had significantly higher estimated blood loss (620 mL vs. 320 mL, p < 0.001), longer operative time (273 vs. 216 min, p = 0.003), and longer hospital stays (16.9 vs. 6.81 days, p < 0.001) compared to the laparoscopic group. There was no difference in lymph node yield or resection status. When comparing open and robotic groups, the robotic procedures yielded a higher number of lymph nodes (24.9 vs. 15.2, p = 0.011) without being significantly longer. The laparoscopic group had a shorter operative time (210 vs. 340 min, p < 0.001), shorter ICU stays (0.63 vs. 1.64 days, p < 0.001), and shorter hospital stays (6.61 vs. 11.8 days, p < 0.001) when compared to the robotic group. There was no difference in morbidity or mortality between the three techniques. Conclusion: The laparoscopic approach exhibits short-term benefits. The three techniques are equivalent in terms of oncological safety, morbidity, and mortality.
引用
收藏
页数:15
相关论文
共 45 条
  • [41] Laparoscopic left hemihepatectomy combined with right lateral hepatic lobectomy in pigs: surgical approach and comparative study of the inflammatory response versus open surgery
    Zhang, Hua
    Tong, Jin-Jin
    Zhang, Zhao-Nan
    Wang, Hong-Bin
    Zhang, Yong-Hong
    VETERINARY RESEARCH FORUM, 2021, 12 (01) : 1 - 6
  • [42] Robotic Dual-Console Distal Pancreatectomy: Could it be Considered a Safe Approach and Surgical Teaching even in Pancreatic Surgery? A Retrospective Observational Study Cohort
    De Pastena, M.
    Salvia, R.
    Paiella, S.
    Deiro, G.
    Bannone, E.
    Balduzzi, A.
    Giuliani, T.
    Casetti, L.
    Ramera, M.
    Filippini, C.
    Montagnini, G.
    Landoni, L.
    Esposito, A.
    WORLD JOURNAL OF SURGERY, 2021, 45 (10) : 3191 - 3197
  • [43] Does Surgical Resection Significantly Prolong the Long-Term Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma? A Cross-Sectional Study Based on 18 Registries
    Li, Zheng
    Zhang, Xiaojie
    Sun, Chongyuan
    Li, Zefeng
    Fei, He
    Zhao, Dongbing
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (02)
  • [44] Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After Whipple's ' s (RAW) study
    Rajagopalan, Ashray
    Aroori, Somaiah
    Russell, Thomas B.
    Labib, Peter L.
    Ausania, Fabio
    Pando, Elizabeth
    Roberts, Keith J.
    Kausar, Ambareen
    Mavroeidis, Vasileios K.
    Marangoni, Gabriele
    Thomasset, Sarah C.
    Frampton, Adam E.
    Lykoudis, Pavlos
    Maglione, Manuel
    Alhaboob, Nassir
    Bari, Hassaan
    Smith, Andrew M.
    Spalding, Duncan
    Srinivasan, Parthi
    Davidson, Brian R.
    Bhogal, Ricky H.
    Dominguez, Ismael
    Thakkar, Rohan
    Gomez, Dhanny
    Silva, Michael A.
    Lapolla, Pierfrancesco
    Mingoli, Andrea
    Porcu, Alberto
    Shah, Nehal S.
    Hamady, Zaed Z. R.
    Al-Sarrieh, Bilal
    Serrablo, Alejandro
    Croagh, Daniel
    HPB, 2024, 26 (08) : 981 - 989
  • [45] Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study
    Labori, Knut J.
    Katz, Matthew H.
    Tzeng, Ching W.
    Bjornbeth, Bjorn A.
    Cvancarova, Milada
    Edwin, Bjorn
    Kure, Elin H.
    Eide, Tor J.
    Dueland, Svein
    Buanes, Trond
    Gladhaug, Ivar P.
    ACTA ONCOLOGICA, 2016, 55 (03) : 265 - 277